A podcast on the key issues in healthcare, featuring innovators from across the industry.
We power our members by building our community and fostering connections through executive peer learning. We support professional growth through talent and development. We accelerate understanding by delivering timely and actionable data and insights on key challenges. And we catalyze transformation by building alliances in areas where the power of the collective is greater than the power of one.
A quick roundup of recent news, including HHS dropping its appeal in an online tracking case, Sesame's new GLP-1 service, and Humana's retreat from MA markets.
A new report by Pitchbook finds that healthcare PE and VC investors are seeing different fortunes through the first half of 2024.
In mid-August, CMS announced that it has negotiated lower Medicare prices for ten widely used drugs, taking advantage of new authorities legislated by Congress in 2022.
Last month, gene therapy pioneer Jim Wilson announced plans to leave his position as director of the University of Pennsylvania's GTP to launch two new companies: Gemma Biotherapeutics and Franklin Biolabs.
Walgreens announced plans to close a substantial number of stores and reduce its investment in VillageMD. Separately, Amazon announced that it is folding its pay-per-visit Amazon Clinic service into One Medical.
This brief has the essential insights extracted from our Medicare Advantage (MA) webinar.
On March 20, CMS announced new Medicare Part D guidance allowing coverage for anti-obesity medications with FDA-approved cardiovascular benefits.
In mid-April, Elevance announced a new strategic partnership with the private equity firm Clayton, Dubilier & Rice.
In Part II of our dive into the behavioral care market, we’re exploring how health systems have turned to virtual or partnership-based solutions, including AI-enabled chatbots.
Epic has released a new feature that makes it easier for patients to securely share medical records with health or wellness apps.
Humana announced plans to lease clinical space and open 23 senior-focused primary care clinics at Walmart stores in the first half of 2025. Financial terms were not disclosed.
Strategy Catalyst has developed a framework outlining six key growth paths beyond the traditional IDN model. This quick reference guide outlines the tactics and key beliefs of each growth path to provide a clear, essential overview.
The FTC is preparing a lawsuit against the three largest PBMs—OptumRx, Express Scripts, and CVS Caremark—over allegations that they steered patients to more expensive drugs in exchange for manufacturer rebates.
